The cooperation integrates Broncus's energy ablation with Healium's ultrasound technology to advance lung cancer treatment by allowing operators in real-time to target, treat and monitor ablated tissues with a single tool. The new technology is expected to deliver more predictable treatment outcomes with increased safety and efficacy while simplifying the procedure flow for interventional pulmonologists (https://www.biospace.com/article/releases/healium-medical-enters-into-strategic-cooperation-agreement-with-broncus-holding-corporation-2216-hk-/)
